Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Estelle Troadec
Daratumumab Induces CD38 Internalization and Impairs Myeloma Cell Adhesion
OncoImmunology
Oncology
Allergy
Immunology
Related publications
The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies
Blood Cancer Journal
Oncology
Hematology
CD38: From Positive to Negative Expression After Daratumumab Treatment
Cureus
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
CD38-driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma
Cancer Research
Cancer Research
Oncology
CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon
Clinical Cancer Research
Cancer Research
Oncology
Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, and Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
CD38 Negative Anaplastic Plasma Cell Myeloma With (14;16) Translocation: A Diagnostic Dilemma for Highly Aggressive Neoplasm: Case Report
Journal of Hematopathology
Forensic Medicine
Pathology
Hematology
Histology
Disseminated Cryptococcosis in a Patient With Multiple Myeloma Treated With Daratumumab, Lenalidomide, and Dexamethasone
Internal Medicine
Internal Medicine
Medicine
Staurosporine Induces Endothelial Cell Apoptosis via Focal Adhesion Kinase Dephosphorylation and Focal Adhesion Disassembly Independent of Focal Adhesion Kinase Proteolysis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology